Clinical trials of hyperthermia using new device for patient with recurrence and/or advanced oral malignancy resistant to standard therapies.

Clinical trials of hyperthermia using new device for patient with recurrence and/or advanced oral malignancy resistant to standard therapies. - Clinical trials of hyperthermia using new device for oral malignancy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015509

Enrollment

Registered

2014-11-01

Start date

2014-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral malignancy

Interventions

Hyperthermia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Oral malignancy Survival expectation>=3 months Performance status: 0-2 Not participate in other trials Not critical organ injury, a bleeding tendency, and infection Participating consent by a free intention

Exclusion criteria

Exclusion criteria: Serious clinical symptoms A life support system, a pacemaker wearing person Psychiatric disorder Immunodeficiency disease Pregnant woman Any other patients whom the investigator has determined to be unsuitable

Design outcomes

Primary

Measure	Time frame
Overall survival time Ungot worse survival time Diagnostic imaging evaluation Observation of tumor	—

Secondary

Measure	Time frame
Adverse event	—

Countries

Japan

Contacts

Public ContactSatoru Shintani

Tokyo Ginza Shintani Clinic, Dental, Oral Director

shintaniclinic@gmail.com03-3538-8148

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026